Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

NewPhase Successfully Completed Small Mammal Pre-clinical Trials of a Cancer Treatment That Transforms Cancer to a Treatable Chronic Ailment
NewPhase Successfully Completed Small Mammal Pre-clinical Trials of a Cancer Treatment That Transforms Cancer to a Treatable Chronic Ailment
TEL AVIV, Israel, April 11, 2016 /PRNewswire/ -- In his State of the Union address, President Obama proposed a "moonshot" to find a cure for cancer.
Opioid painkiller may be new treatment for heroin addiction
Opioid painkiller may be new treatment for heroin addiction
WEDNESDAY, April 6, 2016 -- Hydromorphone -- an opioid painkiller -- may be another treatment option for heroin addiction, a new Canadian study suggests.
AstraZeneca, Eli Lilly study of AZD3293 in early Alzheimer's disease moves into Phase III
AstraZeneca, Eli Lilly study of AZD3293 in early Alzheimer's disease moves into Phase III
AstraZeneca and Eli Lilly announced Friday that a study of the oral BACE inhibitor AZD3293 as a potential treatment for early Alzheimer's disease will continue into Phase III after a positive inte...
Anti-oxidants more effective for elderly with skin cancer
Anti-oxidants more effective for elderly with skin cancer
New York.
FDA OKs Descovy, Gilead Science's Latest Combo HIV Pill
FDA OKs Descovy, Gilead Science's Latest Combo HIV Pill
The Food and Drug Administration has approved Descovy, a combination HIV drug developed by biologic drugmaker Gilead Sciences.
TESARO Announces Global Prostate Cancer Collaboration and Licensing Agreement With Janssen
TESARO Announces Global Prostate Cancer Collaboration and Licensing Agreement With Janssen
WALTHAM, Mass.
$160 billion Pfizer, Allergan inversion scrapped
$160 billion Pfizer, Allergan inversion scrapped
Pharmaceutical firm Pfizer's $160 billion merger with fellow drug giant Allergan died Wednesday, just days after the Obama administration revealed new rules designed to undercut this type of tax i...
Two components in Type 2 diabetes medications may up heart failure risk
Two components in Type 2 diabetes medications may up heart failure risk
                        Alogliptin                                    Saxagliptin The Food and Drug Administration is warning healthcare professionals to consider discont...
This scientist was almost jailed for knowingly publishing fraudulent data
This scientist was almost jailed for knowingly publishing fraudulent data
We'd all like to think that science around the world is being carried out by good, honest, hard-working researchers, who only publish what they know to be the truth according to the standards set ...
Bristol-Myers wins positive CHMP opinion for Opdivo in combination with Yervoy to treat advanced melanoma
Bristol-Myers wins positive CHMP opinion for Opdivo in combination with Yervoy to treat advanced melanoma
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Bristol-Myers Squibb's Opdivo in combination with Yervoy for the treatment of advanced (unrese...
World's smallest diode developed
World's smallest diode developed
The world's smallest diode, the size of a single molecule, has been developed collaboratively by U.
U.S. Treasury rules put Pfizer-Allergan deal in question
U.S. Treasury rules put Pfizer-Allergan deal in question
The U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand